Twin Capital Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-31,540
Closed -$3.7M 285
2019
Q1
$3.7M Buy
31,540
+90
+0.3% +$10.6K 0.18% 160
2018
Q4
$3.43M Sell
31,450
-580
-2% -$63.2K 0.19% 149
2018
Q3
$4.1M Buy
32,030
+2,350
+8% +$301K 0.19% 146
2018
Q2
$3.36M Buy
29,680
+190
+0.6% +$21.5K 0.17% 166
2018
Q1
$3.31M Sell
29,490
-2,000
-6% -$225K 0.17% 162
2017
Q4
$4.66M Buy
31,490
+1,150
+4% +$170K 0.23% 125
2017
Q3
$3.56M Buy
30,340
+5,310
+21% +$622K 0.19% 165
2017
Q2
$3.25M Sell
25,030
-18,626
-43% -$2.42M 0.19% 160
2017
Q1
$5.91M Buy
43,656
+15,308
+54% +$2.07M 0.37% 84
2016
Q4
$4.07M Buy
28,348
+22,798
+411% +$3.27M 0.26% 116
2016
Q3
$655K Sell
5,550
-6,826
-55% -$806K 0.04% 300
2016
Q2
$1.31M Buy
+12,376
New +$1.31M 0.1% 279
2015
Q2
Sell
-15,640
Closed -$2.7M 266
2015
Q1
$2.7M Buy
15,640
+3,850
+33% +$664K 0.24% 132
2014
Q4
$1.53M Buy
11,790
+2,250
+24% +$291K 0.15% 174
2014
Q3
$1.23M Buy
9,540
+600
+7% +$77.2K 0.12% 185
2014
Q2
$791K Sell
8,940
-1,550
-15% -$137K 0.08% 224
2014
Q1
$986K Sell
10,490
-1,460
-12% -$137K 0.1% 214
2013
Q4
$1.35M Sell
11,950
-4,800
-29% -$543K 0.14% 183
2013
Q3
$1.32M Sell
16,750
-6,200
-27% -$489K 0.14% 201
2013
Q2
$1.51M Buy
+22,950
New +$1.51M 0.16% 166